QS inhibition and QQ present promising antimicrobial strategies. By targeting bacterial communication rather than growth, these approaches help mitigate resistance development. Future research should focus on optimizing QQ therapies, integrating them with antibiotics, and enhancing their clinical applications through advanced drug delivery systems to improve treatment outcomes.